Back to resultsEvaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen (GDS)
Primary Purpose
Critical Illness
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
peripheral venous blood gases
Sponsored by
About this trial
This is an interventional other trial for Critical Illness
Eligibility Criteria
Inclusion Criteria: one of this condition in emergency unit : acute respiratory distress a suspicion of an acid-base disorder a state of shock Pathologies requiring monitoring of the respiratory system Patient under NIV Poisoning Coma with a Glasgow score < or equal to 8 Exclusion Criteria: Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases Patient aged < 18 years Pregnant or breastfeeding woman
Sites / Locations
- CAEN University Hospital
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Peripheral Venous Blood Gases
Arm Description
Outcomes
Primary Outcome Measures
lactates on peripheral venous and arterial blood gases
mmol/L
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05971615
Brief Title
Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen
Acronym
GDS
Official Title
Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
January 15, 2020 (Actual)
Primary Completion Date
December 18, 2020 (Actual)
Study Completion Date
December 18, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Caen
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
concordance between the lactate values on peripheral venous and arterial blood gases in all patients receiving an arterial sample on their arrival in the S.A.U.V.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
90 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Peripheral Venous Blood Gases
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
peripheral venous blood gases
Intervention Description
peripheral venous blood gases
Primary Outcome Measure Information:
Title
lactates on peripheral venous and arterial blood gases
Description
mmol/L
Time Frame
baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
one of this condition in emergency unit :
acute respiratory distress
a suspicion of an acid-base disorder
a state of shock
Pathologies requiring monitoring of the respiratory system
Patient under NIV
Poisoning
Coma with a Glasgow score < or equal to 8
Exclusion Criteria:
Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases
Patient aged < 18 years
Pregnant or breastfeeding woman
Facility Information:
Facility Name
CAEN University Hospital
City
Caen
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluate the Relevance of the Use of Peripheral Venous Blood Gases for the Care of Patients in the S.A.U.V (Vital Emergency Rooms) of the CHU de Caen
We'll reach out to this number within 24 hrs